P2D Bioscience Announces Enhanced Patent Position for Lead ADHD Drug CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 26, 2011) - www.p2dinc.com ...

P2D Bioscience Lead ADHD Drug Demonstrates Efficacy in Preclinical Testing CINCINNATI, OH and MUMBAI, INDIA--(Marketwire - Apr 12, 2011) - P2D Bioscience (P2D, Inc.), a pharmaceutical development company, today announced that its lead Attention Deficit/Hyperactivity Disorder...